Aerovate Therapeutics (AVTE) Short Interest Ratio & Short Volume → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free AVTE Stock Alerts $17.45 -0.21 (-1.19%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aerovate Therapeutics Short Interest DataCurrent Short Interest2,190,000 sharesPrevious Short Interest1,880,000 sharesChange Vs. Previous Month+16.49%Dollar Volume Sold Short$46.01 millionShort Interest Ratio13.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares28,810,000 sharesFloat Size18,270,000 sharesShort Percent of Float11.99%Today's Trading Volume298,877 sharesAverage Trading Volume187,705 sharesToday's Volume Vs. Average159% Short Selling Aerovate Therapeutics ? Sign up to receive the latest short interest report for Aerovate Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVTE Short Interest Over TimeAVTE Days to Cover Over TimeAVTE Percentage of Float Shorted Over Time Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. Aerovate Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,190,000 shares $46.01 million +16.5%12.0%13.1 $21.01 4/30/20241,880,000 shares $37.62 million +50.4%10.4%13.1 $20.01 4/15/20241,250,000 shares $31.63 million +25.9%7.2%8.3 $25.30 3/31/2024993,100 shares $29.37 million +9.9%5.8%7.6 $29.57 3/15/2024903,700 shares $24.13 million -10.5%5.3%8.8 $26.70 2/29/20241,010,000 shares $23.31 million -9.8%5.9%10.7 $23.08 Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,120,000 shares $24.24 million +5.7%6.6%11.7 $21.64 1/31/20241,060,000 shares $20.47 million +11.3%6.2%11.8 $19.31 1/15/2024952,100 shares $19.13 million -0.8%5.6%12.6 $20.09 12/31/2023959,300 shares $21.71 million -12.0%5.6%11.7 $22.63 12/15/20231,090,000 shares $19.62 million -10.7%6.4%13.2 $18.00 11/30/20231,220,000 shares $19.17 million -5.4%7.2%16.1 $15.71 11/15/20231,290,000 shares $18.80 million +4.9%7.6%17.8 $14.57 10/31/20231,230,000 shares $13.05 million -8.9%7.1%16.9 $10.61 10/15/20231,350,000 shares $14.85 million -12.3%7.8%18.3 $11.00 9/30/20231,540,000 shares $20.90 million +7.7%8.9%21.3 $13.57 9/15/20231,430,000 shares $18.80 million +5.9%8.3%20 $13.15 8/31/20231,350,000 shares $21.45 million +3.9%7.8%15.9 $15.89 8/15/20231,300,000 shares $19.21 million +4.8%7.5%14.6 $14.78 7/31/20231,240,000 shares $21.64 million +2.5%7.3%14.8 $17.45 7/15/20231,210,000 shares $22.08 million +9.0%7.1%13.9 $18.25 6/30/20231,110,000 shares $19.04 million No Change6.5%12.6 $17.15 6/15/20231,110,000 shares $18.76 million +15.4%6.5%12.2 $16.90 5/31/2023961,900 shares $15.63 million +5.3%6.2%12.3 $16.25 5/15/2023913,900 shares $19.27 million -5.3%5.9%12.6 $21.08 4/30/2023965,000 shares $20.24 million +1.4%6.1%13.5 $20.97 4/15/2023951,300 shares $16.07 million +10.2%6.0%10.3 $16.89 3/31/2023862,900 shares $17.40 million -7.4%5.5%8.9 $20.17 3/15/2023932,200 shares $20.49 million -4.4%5.6%9.6 $21.98 2/28/2023974,600 shares $23.95 million +1.5%5.9%7.2 $24.57 2/15/2023960,000 shares $25.32 million -53.2%5.8%6.3 $26.37 1/31/20232,050,000 shares $46.84 million +0.5%12.4%13 $22.85 1/15/20232,040,000 shares $51.10 million +9.1%12.3%15.5 $25.05 12/30/20221,870,000 shares $54.79 million +11.3%11.3%14.9 $29.30 12/15/20221,680,000 shares $43.09 million +33.3%10.3%13.7 $25.65 11/30/20221,260,000 shares $23.74 million -14.3%7.7%12.2 $18.84 11/15/20221,470,000 shares $28.62 million -3.3%9.0%17.2 $19.47 10/31/20221,520,000 shares $29.66 million +0.7%9.1%21 $19.51 10/15/20221,510,000 shares $29.25 million +2.0%9.1%18 $19.37 9/30/20221,480,000 shares $24.54 million -1.3%8.9%14.4 $16.58Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. 9/15/20221,500,000 shares $23.76 million No Change9.0%13.7 $15.84 8/31/20221,500,000 shares $29.75 million -2.6%9.0%14.8 $19.83 8/15/20221,540,000 shares $39.33 million +10.0%9.3%15.1 $25.54 7/31/20221,400,000 shares $31.15 million +45.4%8.2%13.6 $22.25 7/15/2022963,200 shares $17.34 million +7.6%5.7%11 $18.00 6/30/2022895,600 shares $14.00 million +20.5%6.6%13 $15.63 6/15/2022743,100 shares $9.14 million +6.7%5.5%10.4 $12.30 5/31/2022696,300 shares $8.46 million +17.9%5.1%11.1 $12.15 5/15/2022590,600 shares $7.72 million +17.0%4.3%9.4 $13.07 4/30/2022505,000 shares $6.44 million +3.6%3.0%8.7 $12.75 4/15/2022487,500 shares $8.21 million +4.8%2.9%9.2 $16.84 3/31/2022465,200 shares $8.53 million +6.0%2.8%9 $18.33 3/15/2022438,800 shares $5.27 million +7.1%2.7%8.8 $12.00 2/28/2022409,600 shares $4.01 million -3.7%2.5%7.3 $9.78 2/15/2022425,300 shares $4.32 million -0.6%2.6%7.2 $10.15 1/31/2022427,900 shares $5.06 million -0.7%2.6%6.1 $11.82 1/15/2022431,100 shares $4.09 million -3.4%2.5%6.1 $9.49 12/31/2021446,200 shares $5.26 million -0.2%2.6%3.9 $11.79 12/15/2021446,900 shares $5.51 million +17.7%2.6%3.8 $12.34 11/30/2021379,600 shares $5.20 million +4.4%2.2%2.6 $13.71 11/15/2021363,700 shares $6.35 million -3.3%2.1%2.3 $17.46 10/29/2021376,200 shares $5.99 million +13.7%2.2%2.4 $15.93 10/15/2021330,900 shares $4.68 million -70.2%2.0%2.2 $14.13 9/30/20211,110,000 shares $23.29 million +30.7%6.5%9.6 $20.98 9/15/2021849,100 shares $18.31 million +13.5%5.0%6.1 $21.56 8/31/2021747,900 shares $12.78 million +1.7%4.4%6.8 $17.09 8/13/2021735,600 shares $9.20 million No Change4.6%7.6 $12.50 AVTE Short Interest - Frequently Asked Questions What is Aerovate Therapeutics' current short interest? Short interest is the volume of Aerovate Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 2,190,000 shares of AVTE short. 11.99% of Aerovate Therapeutics' shares are currently sold short. Learn More on Aerovate Therapeutics' current short interest. What is a good short interest ratio for Aerovate Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVTE shares currently have a short interest ratio of 13.0. Learn More on Aerovate Therapeutics's short interest ratio. What is a good short interest percentage for Aerovate Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.99% of Aerovate Therapeutics' floating shares are currently sold short. Is Aerovate Therapeutics' short interest increasing or decreasing? Aerovate Therapeutics saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 2,190,000 shares, an increase of 16.5% from the previous total of 1,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aerovate Therapeutics' float size? Aerovate Therapeutics currently has issued a total of 28,810,000 shares. Some of Aerovate Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aerovate Therapeutics currently has a public float of 18,270,000 shares. How does Aerovate Therapeutics' short interest compare to its competitors? 11.99% of Aerovate Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aerovate Therapeutics: CytomX Therapeutics, Inc. (11.23%), Gossamer Bio, Inc. (5.56%), Immunic, Inc. (3.13%), 89bio, Inc. (10.29%), Leap Therapeutics, Inc. (5.29%), Zai Lab Limited (3.31%), Galapagos NV (2.43%), Keros Therapeutics, Inc. (6.74%), Protagonist Therapeutics, Inc. (5.92%), NewAmsterdam Pharma (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Aerovate Therapeutics stock? Short selling AVTE is an investing strategy that aims to generate trading profit from Aerovate Therapeutics as its price is falling. AVTE shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aerovate Therapeutics? A short squeeze for Aerovate Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTE, which in turn drives the price of the stock up even further. How often is Aerovate Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CytomX Therapeutics Short Interest Data Gossamer Bio Short Interest Data Immunic Short Interest Data 89bio Short Interest Data Leap Therapeutics Short Interest Data Zai Lab Short Interest Data Galapagos Short Interest Data Keros Therapeutics Short Interest Data Protagonist Therapeutics Short Interest Data NewAmsterdam Pharma Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVTE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.